Skip to main content
Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.36
+0.02 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
5.37
+0.01 (0.19%)
After-hours: Apr 28, 2026, 4:47 PM EDT

Abeona Therapeutics Revenue

In the year 2025, Abeona Therapeutics had annual revenue of $5.82M. Abeona Therapeutics had revenue of $5.42M in the quarter ending December 31, 2025.

Revenue (ttm)
$5.82M
Revenue Growth
n/a
P/S Ratio
52.39
Revenue / Employee
$25,752
Employees
226
Market Cap
304.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20255.82M--
Dec 31, 2024---
Dec 31, 20233.50M2.09M147.52%
Dec 31, 20221.41M-1.59M-52.87%
Dec 31, 20213.00M-7.00M-70.00%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cellectis 79.59M
Editas Medicine 40.52M
Foghorn Therapeutics 30.91M
LENZ Therapeutics 19.09M
AC Immune 4.51M
Inhibikase Therapeutics 1.00
Revenue Rankings

ABEO News

More News